NCT00717756View on ClinicalTrials.gov

Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial

PHASE2CompletedINTERVENTIONAL

Enrollment

41

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

December 31, 2013

Study Completion Date

January 31, 2014

Conditions

Liver Cancer

Interventions

DRUG

lenalidomide

25 mg po qd x 21 days then 1 week off equals one cycle

Trial Locations (3)

10467

Montefiore Medical Center, The Bronx

02860

Memorial Hospital of Rhode island, Pawtucket

02903

Lifespan Hospitals, Providence

Sponsors

Lead Sponsor

Brown University

All Listed Sponsors

collaborator

Memorial Hospital of Rhode Island

OTHER

collaborator

Roger Williams Medical Center

OTHER

lead

Brown University

OTHER

NCT00717756 - Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial | Biotech Hunter | Biotech Hunter